This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:


peer-reviewed publication


Expression pattern of key receptors in the hypothalamus revealed

Expression pattern of key receptors in the hypothalamus revealed
Brain slices of the mouse are placed onto a glass slide, for further imaging. Credit: David Ausserhofer

There is growing evidence that peptide hormones from the gut have far-reaching effects on the whole organism. By binding to corresponding receptors in the brain, they can modulate food intake and alter metabolic parameters. However, the role of these peptide receptors in critical developmental phases has not yet been thoroughly investigated.

Scientists of the junior research group Neurocircuit Development and Function at DIfE have investigated this question and studied the expression patterns of key in the mouse hypothalamus. Their newly obtained findings have been published in the journal PLOS ONE.

The hypothalamus is a key region in the that controls metabolism. It is already known that this brain region is affected during development by changes in maternal diet, particularly high-fat and high-sugar diets. However, the underlying mechanisms have been poorly understood.

With this background, the team led by Dr. Rachel Lippert, head of the Junior Research Group Neurocircuit Development and Function, has investigated three main receptors for peptide hormones from the gut and their regulation in the hypothalamus during the first three weeks of life in a mouse model. This developmental phase in mice corresponds roughly to the last trimester of pregnancy in the context of brain development in humans.

The receptors studied were the gastric inhibitory polypeptide receptor (GIPR), the glucagon-like peptide-1 receptor (GLP1R), and the cholecystokinin receptor 2 (CCK2R). All three receptors play important roles in , food intake, and energy balance. In addition, they have gained popularity as potential therapeutic targets for the treatment of obesity and diabetes.

However, before one can investigate how the peptide hormones from the gut and their receptors in the hypothalamus change under certain nutritional conditions, the baseline condition must first be established. At fixed time points within the first three weeks of life, the researchers removed tissue from the hypothalamus of the offspring to determine the expression patterns of the three receptors.

"Only when we understand how these receptors change during development can we ask the next questions regarding their role in the formation of neuronal networks," emphasizes Lippert, whose findings are the first publication of her junior research group, which was founded in 2020.

Contrary to the researchers' expectations, GIPR expression showed a significant decrease during development. In contrast, GLP1R expression increased steadily during early postnatal development. In the expression of CCK2R during the postnatal period, the researchers detected a sex-specific pattern. While CCK2R expression increased significantly in male mice during development, it remained nearly constant in female mice.

This suggests a different role for this receptor in the sexes. "Our results suggest that the developing brain responds to peripheral metabolic signals. This is evidenced by dynamic regulation of the studied receptors during early development in the brain," emphasizes first author Dr. Lídia Cantacorps.

Connections uncovered

In a further step, the scientists investigated the potential correlations between receptor expression and physiological parameters such as body weight and blood glucose level. While no significant correlations were found for blood glucose levels, a clear correlation was found between receptor expression and body weight. Both GLP1R and CCK2R were positively correlated with , while GIPR expression showed a significant negative correlation.

This comprehensive analysis highlights the complex interplay between gut-derived peptide hormones and their receptors during brain development. The discovery of the developmental dynamics of these receptors paves the way for a deeper understanding of how circulating gut hormones derived from the mother influence brain development in the offspring.

"Our findings contribute to our future ability to study the impact of unhealthy maternal diets on the circulation of gut-derived peptide hormones on offspring growth and brain development," Lippert explains. In addition, the results increase the potential for refining therapeutic strategies and interventions to treat metabolic disorders and provide insights into the complex interrelationship between metabolism and brain development.

Background information about the three receptors

The gastric inhibitory polypeptide receptor (GIPR) is expressed in pancreas, stomach, heart, kidney, liver, adipose tissue, and brain. It functions as a signal mediator in the gut-brain axis. While activation of the receptor in the pancreas stimulates insulin release, in the brain it causes reduced food intake and weight loss.

The Glucagon-like peptide-1 receptor (GLP1R) is expressed in pancreas, lung, stomach, heart, kidney and brain. It is involved in the control of blood glucose levels by stimulating insulin release in the pancreas. Activation of the receptor in the hypothalamus results in reduced .

The Cholecystokinin receptor 2 (CCK2R) is highly expressed in the brain, particularly in the hypothalamus. It functions as a signaling mediator in the gut-brain axis and is involved in digestion, emotion, and memory regulation.

More information: Lídia Cantacorps et al, Gut-derived peptide hormone receptor expression in the developing mouse hypothalamus, PLOS ONE (2023). DOI: 10.1371/journal.pone.0290043

Journal information: PLoS ONE

Provided by Deutsches Institut für Ernährungsforschung Potsdam-Rehbrücke
Citation: Expression pattern of key receptors in the hypothalamus revealed (2023, August 24) retrieved 7 December 2023 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

New targets for the development of a drug treatment for obesity and type 2 diabetes


Feedback to editors